Showing results (1-10 of 4,269) with videos related to
Sort By:
Pageof 427
Current Drug Discovery Technologies|January 27, 2026
Cyclic Peptides in Wound Hydrogels: Current Advances and Future DirectionsShahjad, Yashika Garg, Arun Kumar, et al.Current Topics in Medicinal Chemistry|January 25, 2023
Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and CancerSisir Nandi, Bhumika Chauhan, Heena Tarannum, et al.Current Drug Targets|July 29, 2020
To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing Co-crystallized Ligand to Combat HCVHeena Tarannum, Bhumika Chauhan, Asmita Samadder, et al.Journal of Basic and Clinical Physiology and Pharmacology|July 26, 2019
A rare case of clomiphene-induced leukocytoclastic vasculitisYashika Garg, Sourabh Jain, Arun KumarIndian Journal of Pharmacology|January 6, 2016
A rare case of isoniazid-induced erythrodermaYashika Garg, Rajeshwari Gore, Sourabh Jain, et al.Indian Journal of Pharmacology|March 9, 2018
Comparison of Clinical Effectiveness and Safety of Newer Nonsteroidal Anti-inflammatory Drugs in Patients of Osteoarthritis of Knee Joint: A Randomized, Prospective, Open-label Parallel-group StudyYashika Garg, Jatinder Singh, H S Sohal, et al.Recent Patents on Biotechnology|July 30, 2016
Recent Advances in Ligand and Structure Based Screening of Potent Quorum Sensing Inhibitors Against Antibiotic Resistance Induced Bacterial VirulenceSisir NandiSpringerplus|October 13, 2017
In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptorsNeha Parihar, Sisir NandiCombinatorial Chemistry & High Throughput Screening|January 21, 2021
Repositioning of RdRp Inhibitors Against HCV NS5B Polymerase Utilizing Structure-Based Molecular DockingHeena Tarannum, Sisir NandiCurrent Pharmaceutical Design|September 5, 2019
In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead DiscoveryHarekrishna Roy, Sisir NandiPageof 427